glp 1 drugs and rheumatoid arthritis GLP-1s for diabetes reduce arthritis, gout risk Could this treatment END Rheumatoid

Endocrinology 2025

is a speaker/consultant for Boehringer Ingelheim, Janssen, Lilly, Mannkind, and Novo Nordisk

and 8.3% after 12 months

How could a hormone produced in our gut that regulates appetite, satiety and glucose levels be so deeply intertwined to our biology have such multi-factorial effects

Starting treatment after lactation completes eliminates theoretical infant exposure while allowing mothers to pursue sustainable metabolic health improvements with clinical support

When quality assurance teams look at peptide providers, they should make sure that the methods used to make the products reduce the amount of endotoxin and other impurities that could make adverse responses worse